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Abstract
Photoreceptor degeneration is a common feature of ciliopathies, owing to the importance of the 
highly specialized ciliary structure of these cells. Absence of AHI1, which encodes a cilium-
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localized protein, has been shown to cause a form of Joubert syndrome highly penetrant for retinal 
degeneration1,2. We show that Ahi1 knockout mice fail to form outer segments (OS), and show 
abnormal distribution of opsin throughout photoreceptors. Apoptotic cell death occurs rapidly 
between 2-4 weeks of age and is significantly delayed by reduced dosage of opsin. This phenotype 
also displays dosage-sensitive genetic interactions with Nphp1, another ciliopathy gene. Although 
not a primary cause of retinal blindness in humans, an allele of AHI1 modifies the relative risk of 
retinal degeneration greater than 7 fold within a nephronophthisis cohort. Our data support 
context-specific roles for AHI1 as a contributor to retinopathy and may explain a proportion of the 
variability of retinal phenotypes observed in nephronophthisis.
Ciliopathies comprise an increasingly diverse group of genetic disorders, united by their 
connection to primary cilia and/or basal body dysfunction3. Because of the pervasiveness of 
this organelle, these disorders manifest in numerous organs. Joubert syndrome (JS, i.e. 
cerebellar hypoplasia), Leber congenital amaurosis (LCA, i.e. congenital retinal blindness) 
and nephronophthisis (NPHP, i.e. fibrocystic renal disease) primarily affect three organs 
frequently diseased in ciliopathies, namely cerebellum, retina and kidney. These diseases are 
highly genetically heterogeneous and are sometimes variable even within single families, 
undermining the predictive value of diagnostics and genetic counseling. Though many 
causative genes have been identified for these Mendelian disorders, our current 
understanding of the genetics and potential mechanisms is insufficient to explain this 
variability, and suggests involvement of genetic modifiers.
Mutations in AHI1 are identified in 12% of patients with JS and 20% of patients with JS + 
LCA1,2,4,5, though AHI1 mutations are not known to cause non-syndromic LCA. AHI1 
protein, or jouberin, contains an N-terminal coiled-coil region, seven WD40 repeats and an 
SH3 domain6 and interacts with nephrocystin-1 (NPHP1)7, the gene for which is the most 
commonly mutated in juvenile NPHP8,9. To study AHI1 in ciliopathogenesis, we generated 
targeted conditional and null alleles of murine Ahi1, flanking exons 6-7 with loxP sequences 
(Supplementary Fig. 1a). Homozygous germline mutants were runted and exhibited high 
mortality (Supplementary Fig. 1c,d). Brain morphology was grossly preserved and neuronal-
specific conditional knockouts (Ahi1 Nestin cKO) showed nearly Mendelian ratios at 
weaning age (data not shown), suggesting effects outside of the nervous system on survival.
Histological analysis of the retina revealed rapid loss of the outer nuclear (photoreceptor) 
layer with few nuclei remaining by age one month in Ahi1 germline null mice (Ahi1−/−, Fig. 
1a). As early as P10, transmission electron microscopy showed complete absence of both 
rod and cone outer segments (OS, specialized disk-shaped membranes of photoreceptor 
cilia, Fig. 1b, and Supplementary Fig. 2a). This well-preceded the initiation of apoptotic cell 
death, apparent by ~3 weeks of age, as indicated by activated caspase-3 expression (Fig. 1c). 
Photoreceptor ciliary axonemes were intact and had normal 9+0 microtubule doublet 
configuration (Fig. 1b, Supplementary Fig. 2b), arguing against a role in axonemal 
development. Dark-adapted electroretinograms (ERG) from Nestin-Cre conditional mutants 
(Ahi1 Nestin cKO) and controls preceding cell loss confirmed absence of activity (Fig. 1d). 
Consistent with its putative role in cilia function, we found Ahi1 was enriched at the 
connecting cilium and basal body, and overlapped with centrin-2 (centriole/transition zone 
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marker10,11) transgene expression (Fig. 1e). This expression pattern was reminiscent of 
ciliary transport molecules such as Ift8812 and also other ciliopathy-associated molecules 
like Nphp113. These results reveal specific defects of OS morphogenesis and photoreceptor 
survival associated with absence of Ahi1.
Rhodopsin (rod opsin and cofactor, retinal), responsible for initiating the first steps in light-
dependant signal transduction, is also necessary for OS formation14-17. Disruptions of genes 
required for ciliary transport result in mislocalized opsin and OS defects12,18-20, prompting 
us to test for opsin localization in Ahi1−/− retina. We found severely disturbed opsin 
distribution as early as P10 (Fig. 2a). We quantified this in immunogold-labeled sections, 
which showed significantly increased inner segment labeling in mutants, both in the 
cytoplasm (IS) and particularly, along inner segment plasma membranes vs. controls (PM, 
Fig. 2b and Supplementary Fig. 2c). This difference was ~10-fold for both IS and PM (P= 
8.0E-06 and 2.2E-07, respectively). Some other proteins implicated in OS morphogenesis 
appeared grossly intact (Supplementary Fig. 2d). We conclude opsin is significantly mis-
accumulated in Ahi1−/− mice at an early stage of OS morphogenesis.
To further test for cell-type-specific requirements for Ahi1 in opsin distribution, we used 
Ahi1flox/flox mice in a series of retinal in vivo electroporation experiments performed at P0 
(Supplementary Fig. 3a). The pCAG-Cre:GFP vector drives Cre:GFP under the constitutive 
chick beta-actin promoter, and was used with pDsRed-CALNL recombination reporter21,22. 
Photoreceptors with evidence of Cre recombination based upon expression of DsRed also 
showed recapitulation of the opsin redistribution phenotype by one month of age 
(Supplementary Fig. 3b), indicating a requirement for Ahi1 in photoreceptors. To test for 
temporal-specific requirements for Ahi1, these experiments were repeated using instead 
pCAG-ERT2CreERT2, which activates Cre under control of 4-hydroxytamoxifen (4-
OHT)22. Following 4-OHT dosage at P14, after the peak of OS development, we did not 
detect opsin accumulation at 2 and 4 weeks past Cre induction, despite evidence of 
recombination based upon expression of DsRed (n=2, Supplementary Fig. 3c,d). We 
conclude Ahi1 displays temporal specificity in its function in photoreceptors, possibly akin 
to the time dependance reported for ciliary transport machinery in kidney phenotypes23. 
These data also suggest other factors might be contributing to OS developmental defects in 
this model.
Mislocalized opsin is frequently associated with retinal degeneration in animal models19,24, 
and has been indicated as a major cause of photoreceptor cell death in the absence of 
heterotrimeric kinesin-2 function (D. Jimeno, V.S. Lopes, K. Khanobdee, X. Song, B. Chen, 
S. Nusinowitz, D.S. Williams, unpublished data). Because of the striking accumulation of 
opsin in Ahi1−/− mice, we hypothesized this might similarly contribute to cell death in 
Ahi1−/− photoreceptors. To test this directly, we reduced opsin levels in Ahi1−/− mice by 
introducing a rod opsin null allele15 into the Ahi1−/− background. Rho+/− photoreceptors 
have approximately 40-50% reduction in opsin content15,25. Reduction in opsin dosage did 
not affect OS formation, showing similar absence of OS in Ahi1−/−Rho+/− compared to 
Ahi1−/− (Supplementary Fig. 4), but significantly delayed the cell loss seen in the Ahi1−/−. 
We found nearly complete rescue of cell numbers at three weeks of age (n=3-7, P=0.00175) 
and partial rescue at one month (Fig. 3, n=3-4, P=0.00613). These data support the 
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hypothesis that abnormal accumulation of opsin contributes to the loss of Ahi1−/− 
photoreceptors.
Mutations in NPHP1 cause juvenile nephronophthisis with partially penetrant retinopathy. 
To study Nphp1 in the mouse, we generated a targeted disruption of Nphp1 by insertion of a 
neobpA cassette into exon 4, generating a null allele, and confirmed absence of Nphp1 
expression (Supplementary Fig. 5a,b,c). The photoreceptors of Nphp1neo/neo mice (hereafter 
denoted as Nphp1−/−) formed OSs but underwent gradual retinal degeneration, slightly 
evident at 2 months (Supplementary Fig. 5d). This was milder than an independently 
targeted Nphp1 mutant reported to show failure of OS formation followed by retinal 
degeneration26. Since both Nphp1 alleles are predicted to function as nulls, this difference in 
severity of retinal phenotypes suggests the influence of genetic modifiers.
To test whether genetic interaction of Ahi1 and Nphp1 can influence phenotypic expression 
in vivo, we examined double mutant combinations of Ahi1 and Nphp1, ranging from single 
heterozygotes to knockout; heterozygote combinations, for outer nuclear layer (ONL) 
thickness and for mislocalized opsin. To efficiently obtain genotypes homozygous null for 
Ahi1, we used the Ahi1flox allele and the distal (peripheral) retina-specific Pax6α-Cre 
transgene27 to circumvent the lethality issues associated with Ahi1−/−. We observed trends 
of increasing severity of cell loss and opsin redistribution with additional deleterious alleles, 
with the Ahi1 null allele showing a stronger effect (Fig. 4a). Specifically we found 
significantly decreased ONL thickness and increased ONL-localized opsin when we 
compared Nphp1−/−Ahi1+/− against Nphp1−/− and Ahi1+/− controls at P21 (Fig. 4b). The data 
suggest dosage sensitive genetic interactions between Ahi1 and Nphp1 in retinal 
development.
Based on the pronounced retinopathy in Ahi1−/− mice, we next tested whether AHI1 was 
mutated in humans with isolated LCA. In a screen of AHI1 coding exons from well-
characterized LCA patients (US, Canada, Netherlands, Spain, prescreened for known genes; 
n=176), no homozygous or compound heterozygous deleterious changes were identified, but 
one variant, p.R830W/c.C2488T, heterozygous in 9 independent cases, was of particular 
interest, though not significantly enriched (data not shown). In addition to conservation of 
p.R830 throughout vertebrate homologs, a change from arginine to tryptophan (from a polar 
basic residue to a nonpolar hydrophobic residue) is predicted to be damaging (Polyphen28, 
SNPs3D29). This coupled with its position within the WD40 repeat domain (between two 
blades of its predicted propeller structure, Supplementary Fig. 6a,b) suggests this mutation 
may interfere with the function of AHI1, perhaps in protein-protein interactions.
To test whether this change altered sedimentation of AHI1 complexes in vitro, we expressed 
GFP-AHI1R830W, GFP-AHI1WT or GFP-EV (empty vector) in HEK293T cells with 
untagged human rhodopsin30 (RHO) and assayed lysates by sucrose density gradients 
(Supplementary Fig. 6c). We identified two distinct sedimentation peaks containing AHI1 
which appeared at lower intensity for GFP-AHI1R830W transfected cells, suggesting 
underrepresentation of p.R830W in complexes, despite comparable total expression levels of 
p.R830W in HEK293T cells (Supplementary Fig. 6d). Furthermore, opsin was shifted 
towards lower density complexes in cells expressing p.R830W vs. those expressing wildtype 
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AHI1 or empty vector. This supports potentially hypomorphic effects of p.R830W, perhaps 
in complex stability or formation. This variant has been mentioned as a polymorphism in 
several AHI1 studies1,2,31,32, but the effect of this change on retinal disease has not been 
explored. Due to the genetic interaction of Ahi1 and Nphp1 in mouse, and the variable 
association of retinal degeneration (RD) with nephronophthisis (Senior-Løken syndrome, 
SLSN33), we hypothesized that AHI1 p.R830W might contribute to the risk of retinopathy in 
nephronophthisis patients.
We thus genotyped 153 independent nephronophthisis cases from Italy (of which 16 have 
RD), and 306 ethnically-matched healthy controls for the p.R830W (c.C2488T) change. We 
found the T allele frequency was significantly higher in patients with NPHP+RD versus 
NPHP patients excluded for RD (25% vs. 1.8%, P=5.36E-06, Table 1) and versus controls 
(25% vs. 2.8%, P=9.03E-06, Table 1). This translated to a relative risk of 7.5 (95% CI 
4.0-11.2) associated with AHI1 p.R830W for retinal degeneration within NPHP patients. To 
determine if this association depended upon the primary gene mutation, we repeated this 
analysis after subdividing cases into those with NPHP1 mutations (either homozygous 
deletion or compound heterozygous mutation) vs. those without NPHP1 mutations. 
p.R830W continued to be significantly associated with NPHP+RD irrespective of the 
primary mutation (Table 1).
To test for population stratification, we also examined transmission of p.R830W in this 
cohort34 by genotyping parents of 117 available trios. We found 17 informative trios where 
one parent was heterozygous for c.C2488T. Although this sample size was too limited for 
full TDT analysis, we found the T allele was over-transmitted to NPHP+RD patients. 
Specifically, T was transmitted 100% of the time to NPHP+RD patients (n=7, P<0.01, chi-
squared), but only 50% of the time to NPHP patients without RD (n=10, no significant 
difference from the null hypothesis). This association was apparent when evaluating single 
families; for example, in one family with three NPHP affecteds33, p.R830W segregated only 
with the sibling displaying absent ERG response, while the others retained visual function. 
Our results support the role of AHI1 as a modifier of retinal degeneration in the context of 
mutations leading to NPHP.
That this AHI1 allele is associated with retinal disease in as much as half of SLSN patients 
in this Italian population, suggests other rarer mutations of AHI1 may behave similarly. 
Results from the mouse model support a role for Ahi1 in cilia-associated trafficking 
mechanisms, consistent with those of a recent study describing Ahi1 in cultured cells35. We 
also identify a new role for Ahi1 in photoreceptor development and demonstrate the utility 
of mouse genetic interaction in identifying loci conferring high risk alleles for disease. A 
similar effect was presented with one variant of RPGRIP1L36, supporting the role of 
modifiers in phenotypic expressivity of ciliopathies. Given the complexity of ciliopathy 
phenotypes, it is likely other variable phenotypes could also be explained by modifiers. 
Intriguingly, a population of JS patients (n=155) did not reveal a significant difference in 
frequency of p.R830W although it was slightly higher relative to controls. These patients 
were ascertained for phenotypes associated with a specific constellation of midbrain-
hindbrain malformations, but also variably present with renal and/or retinal dysfunction. 
Lack of significant association within JS may reflect more complex interactions at the 
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molecular level, requiring specific disruptions to alter phenotypic expression. Future 
screenings at other loci may help elucidate these distinct but overlapping mechanisms. Our 
example within the ciliopathies shows that mutational analysis of other causative genes from 
the broader clinical spectrum can yield substantial insight into the genetics and pathogenesis 
of heterogeneous syndromic disorders.
Online Methods
Subjects and mutational screening
Subjects were ascertained from populations of European ancestry (Italian, French/French 
Canadian, Spanish, Dutch) based on clinical features specific to LCA, NPH, and JSRD 
(exception of NPH group, mostly Italian). In particular, NPHP patients were ascertained 
over 15 years at the Nephrology Center of the G. Gaslini Childrens Hospital (Genoa, 
Italy)37. Diagnosis of NPHP was based on bio-clinical tests, kidney and liver ultrasound, 
ophthalmologic examination, and molecular tests (for NPHP1 deletion and/or mutations). 
All patients showed clinical and laboratory signs of NPHP, including urinary concentration 
defect, increase of serum creatinine levels above the normal range for age, and small 
hyperechoic kidneys without cortico-medullary differentiation. >70% patients had already 
developed ESRF (End-Stage Renal Failure) and most with ESRF had been transplanted. 
Patients with possible neurological involvement underwent detailed neurological testing, 
including brain MRI and EEG. JSRD patients were ascertained through the International 
JSRD Study Group, referring patients from several countries worldwide. The clinical 
diagnosis was confirmed by brain neuroimaging showing the typical “molar tooth sign”. A 
standardized clinical questionnaire was obtained to assess extent of multiorgan involvement. 
Control subjects were drawn from the same populations and represent healthy subjects with 
respect to the clinical signs of interest. Informed consent was obtained for all subjects 
according to approved institutional human subjects protocols (Human Research Protection 
Program Committees of UCSD, La Jolla and CSS-Mendel Institute, Rome).
Exons were PCR-amplified and sequenced using BigDye Terminator chemistry (ABI Prism 
3100), and chromatograms were analyzed visually; or PCR fragments were analyzed on a 
DHPLC-based WAVE DNA Fragment Analysis System (Transgenomic, Crewe, United 
Kingdom). Samples with abnormal elution profiles underwent direct bidirectional 
sequencing as above. Primer sequences were published previously1.
Knockout and transgenic mice
Animals were used in compliance with approved Institutional Animal Care and Use 
Committee protocols.
Generation of Ahi1 mutant mice—Ahi1 conditional (“flox”) and null allele mice were 
generated by targeted homologous recombination. The floxed region (containing exons 6-7), 
and flanking homology arms of Ahi1 were PCR-amplified from 129/SvJ genomic DNA; 
flanked with SalI, BamHI, and XhoI restriction sites; and subcloned into the modified pflox 
vector38(J. Marth) containing PGKneobpA (positive selection) and HSV-TK (negative 
selection). This was linearized with SbfI and transfected into 129SvJ-derived ES cells. G418 
Louie et al. Page 6
Nat Genet. Author manuscript; available in PMC 2010 August 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
and gancyclovir resistant clones were selected, 9 correctly recombined ES clones were 
identified by Southern blot with two distinct probes, and two clones were injected into 
C57Bl/6 blastocysts. High percentage chimeras were bred to C57Bl/6 for germline 
transmission and to EIIa-Cre to generate mosaic Cre recombinants. Mosaics were bred to 
C57Bl/6 to isolate null and conditional alleles. Mice were genotyped by PCR in a multiplex 
reaction, amplifying a 206bp (null allele), a 297bp (wildtype) and/or a 399bp (conditional) 
product (Supplementary Table 1).
Generation of Nphp1 mutant mice—To clone the mouse Nphp1 locus, a 129/Ola 
genomic cosmid library (obtained from the Resourcenzentrum Berlin) was probed using the 
mouse cDNA. A single cosmid clone was purified, and a 10 kb SacI and 12 kb EcoRI 
fragment harboring the exon 4 region of the Nphp1 transcription unit were subcloned and 
characterized by restriction mapping. To generate targeting construct for Nphp1, a 12.5 kb 
genomic fragment derived from the two subfragments was modified by inserting a floxed 
PGK-neobpA cassette (pMC1-neo-polyA) into an unique NheI site. The targeting vector was 
linearized at a unique SalI site and introduced into E14 ES cells39. 159 G418-resistant 
colonies were screened by Southern blot analysis and four correctly targeted ES cell lines 
were identified. Nphp1neo/+ ES cells (129/Ola) were microinjected into NMRI albino mouse 
blastocysts to generate chimeras. Males with high degree of chimerism were mated to NMRI 
females for germline transmission. F1 heterozygous males were crossed to NMRI females, 
and heterozygous offspring were intercrossed.
Mice were genotyped by Southern blotting using a BamHI RFLP with the floxed neo-
cassette (wildtype allele: 40 kb, mutant: 20 kb), or by PCR, with primers amplifying a 120bp 
fragment (wildtype) and a 1600bp fragment (mutant) (Supplementary Table 1).
Rhodopsin null mice were obtained from Janis Lem15. The following transgenic mouse lines 
were used: EIIa-Cre40, Nestin-Cre (Jax: 00377141), Pax6α-Cre27 and GFP-Centrin210. Ahi1 
alleles were denoted as follows: Ahi1−/−, Ahi1+/− (homozygous germline null, germline 
heterozygote: used for all experiments except where indicated otherwise), Ahi1 Nestin cKO 
(Ahi1flox/−Nestin-Cre+: used for ERGs), Ahi1 Pax6α cKO (Ahi1flox/−Pax6α Cre+, only 
more peripheral region analyzed: used for generating double mutants with Nphp1). All 
animals were from mixed backgrounds (C57Bl/6, SvJ129, 129/Ola) and compared to 
littermate or age-matched sibling controls.
Dark-adapted ERG
Mice were tested using previously described methods42. Mice dark-adapted overnight were 
kept under low red lighting and anesthetized by intraperitoneal (IP) injection (10mg/ml 
ketamine, 1mg/ml xylazine at 0.1ml/10g body weight), dilated with phenylephrine HCl and 
tropicamide, and kept on a warm pad. Gold loop electrodes on the cornea were referenced to 
needle electrodes under the cheek, while electrodes clipped to ears served as grounds. 
Responses were elicited by high intensity flashes (averaged over n=5) at one second 
intervals over a time base of 500 ms in a Ganzfeld dome with a photostimulator (Model 
PS22, Grass instrument company, Quincy, MA).
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Antibodies and fluorescence microscopy
Mice were anesthetized by isoflurane inhalation and perfused, or eyes were immersed in 4% 
paraformaldehyde/PBS. 10-25μm cryosections sections corresponding to a medial position 
(intersecting optic nerve) were stained for immunofluorescence per standard protocols 
except where noted. We used the following primary antibodies: rabbit anti-Ahi143 (1:250, 
after antigen retrieval by microwaving slides for 15 minutes in 10mM sodium citrate, pH 
6.0), mouse anti-acetylated tubulin (Zymed, 6-11B-1, 1:1000), rabbit anti-RPGR (T. Li, 
1:1000 on barely fixed tissues as previously described)44, chicken anti-RP145 (1:2000, E.A. 
Pierce), mouse anti-opsin (1:250, Chemicon). We used Alexa Fluor dyeconjugated 
secondary antibodies (1:750, Invitrogen/Molecular Probes) and Hoescht 33342 (1:10,000) 
nuclear dye. Images were obtained on a Fluoview1000 Spectral Deconvolution Confocal 
microscope (Olympus), under the same parameters/experiment.
Opsin immunofluorescence measurements were determined from raw images using NIH 
ImageJ software (“Measure RBG” plugin). ONL values were normalized to values from the 
apical region encompassing IS and OS. Measurements were made on comparable regions of 
the retina (minimum two/section, from central and peripheral and averaged together, with 
exception of Pax6a-cre cKOs, for which all measurements were from peripheral/distal 
regions).
Histology and electron microscopy
For conventional EM, samples were fixed with 2% paraformaldehyde/2% glutaraldehyde/
0.1M cacodylate buffer and embedded in propylene oxide:Epon 812 resin. Semithin (0.7μm) 
sections were stained with toluidine blue (0.25% toluidine blue+0.25% sodium borate in 
water) for light microscopy. Ultrathin sections (70nm) for electron microscopy were 
collected on copper grids and stained with saturated uranyl acetate and lead citrate solution 
prior to imaging on a Phillips electron microscope (model 208).
For immuno-electron microscopy, mice were perfused with 4% paraformaldehyde and 
samples were immersed overnight in 0.1% glutaraldehyde/4% paraformaldehyde/0.1M 
cacodylate buffer, and embedded in LR White resin (EMS, USA). 70nm sections were 
etched with saturated sodium periodate and blocked with 4% bovine serum albumin. 
Sections were incubated with anti-opsin (1D4) primary antibody and with goat anti-rabbit 
IgG secondary conjugated to 12nm gold (EMS, USA). Sections were subjected to osmium 
vapour and stained with uranyl acetate and lead citrate. Negative control sections were 
processed simultaneously and included sections not incubated with primary antibody. Cilia 
were randomly selected for imaging on a TEM microscope (Zeiss).
In vivo electroporation and 4-OHT treatment
Retinal in vivo electroporation at P0 was performed as previously described21,22 using 
5μg/μl total plasmid DNA with 0.01% Fast Green tracer at 0.5μl/eye at the following mass 
ratios: pCAG-Cre:GFP/pCALNL-DsRed (1:1), and pCAG-ERT2CreERT2/pCALNL-
DsRed/pCX-EGFP (2:1:1), but with a modification: DNA solutions were injected through 
glass micropipets pulled from capillary tubes (World Precision Instruments, TW150F-3). 
Plasmids were from C. Cepko through Addgene. For ERT2Cre induction, 4-OHT (Sigma, 
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H7904) was prepared in corn oil (Sigma, C8267) at 2mg/mL and IP injected (400μl/2 week 
old mouse).
Cell culture and transfection
HEK293T (human embryonic kidney) cells were seeded on 10cm plates and transfected at 
90-95% confluency by Lipofectamine2000 (Invitrogen) using 24μg total DNA/plate. Cells 
were lysed 24 hours later for analysis.
Western blotting and sucrose fractionation
Western blotting was performed on lysates prepared in modified RIPA buffer using the 
following antibodies: rabbit anti-Ahi1, mouse anti-GFP (Covance, B34), mouse anti-α-
tubulin (Sigma, T-6074), and mouse anti-rhodopsin (Chemicon, MAB5316). All antibodies 
were diluted 1:1000 in 4% milk. Secondary detection was performed using HRP-conjugated 
anti-mouse or anti-rabbit antibodies (1:20,000, Zymax) in 4% milk. For sucrose 
fractionation, modified RIPA lysates were loaded onto step-wise gradients from 5% to 60% 
sucrose followed by ultra-centrifugation overnight at 100,000 g force. Fractions were 
collected from the top and protein was precipitated using trichloro-acetic acid followed by 
SDS-PAGE and western blotting.
Statistics
For the association studies, two-tailed P values were computed using Fisher’s exact test by 
http://www.langsrud.com/fisher.htm using the sum of small P values method. The TDT (chi-
squared) statistic34 was computed manually with P value assigned for 1 degree of freedom. 
Relative risk and confidence intervals were computed by http://statpages.org/ctab2x2.html 
based on a general method46. For other studies, data were expressed as means +/− S.E.M. 
Two-tailed P values were calculated by Student’s t-test. Values less than 0.05 were 
considered statistically significant for all tests.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Degeneration of photoreceptor cells following failed outer segment development in Ahi1−/− 
mouse retina. (a) Semi-thin sections of retina stained with toluidine blue from P10 to adult 
(10 wks) showing acute loss of the outer nuclear layer (ONL) between P21 and P30. 
Scale=20μm (b) Transmission electron microscopy from P10. Outer segments (OS, 
brackets) are present in Ahi1+/−, but not in Ahi1−/−. Connecting cilia (CC, arrowheads) 
present in both. Scale=0.5 μm (c) Photoreceptor cell death is evident before three weeks of 
age, indicated by activated caspase-3 immunofluorescence (green) from 20μm cryosections. 
Nuclei are stained with Hoescht 33342 (blue). Shown are representative images from P19 
mice, scale=20μm. (d) Full field dark-adapted electroretinograms (ERGs) from P19 
Ahi1flox/−; Nes-Cre+ (Ahi1Nestin cKO) and Ahi1 heterozygous control mice. Shown are 
representative waveforms from n=3-4 mice/genotype. (e) Endogenous Ahi1 localization 
(red) to base of photoreceptor connecting cilium (acetylated-tubulin: green) in Ahi1+/− 
section is absent in Ahi1−/− cilium. Ahi1 distribution overlaps with centrin-2 (green) in GFP-
Cetn-2 transgenic mouse retina. Arrowheads indicating example GFP-centrin2 labeled 
connecting cilia, 10μm cryosections, scale=5μm. Ahi1 immunoelectron microscopy from 
P10 retina, showing particles at the basal body (BB) and along the cilium (CC), 
scale=0.25μm
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Figure 2. 
Opsin accumulation in Ahi1−/− photoreceptors (a) Opsin immunofluorescence (green) at 
P10 in Ahi1+/− and Ahi1−/− retina from cryosections. Nuclei are stained with Hoescht 33342. 
Scale=20μm (b) Opsin immunoEM and quantification of immunogold labeling from 
ultrathin sections of P10 Ahi1+/− and Ahi1−/− retina, n=20-23 photoreceptor connecting cilia/
genotype. Data are expressed as number of gold particles per μm2 area within the inner 
segment (IS, defined as within inner segment and at least 30nm away from PM, P=8.0E-06), 
and as number of particles per μm length of inner segment membranes (PM, dashed lines, 
P=2.2E-07). Black arrowheads indicate examples of abnormally localized opsin, 
CC=connecting cilium, scale=0.5μm, error bars represent s.e.m.
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Figure 3. 
Opsin contributes to cell death in Ahi1−/− mice. 10μm cryosections from P21 and P30 retina 
showing delay of cell loss associated with reduced opsin dosage (Ahi1−/−Rho+/−), measured 
as average number of cells/column (nuclei were stained with Hoescht 33342 and counts 
expressed as average of three counts across each section). Asterisk in top panel denotes 
significant difference from both control and rescue, n=3-7, P=0.00175 (P21) and 0.00613 
(P30), scale=10μm, error bars represent s.e.m.
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Figure 4. 
Genetic interaction of Ahi1 with Nphp1. (a) Increased cell loss and redistribution of opsin 
with increased load of deleterious Ahi1 and Nphp1 mutations in mouse retina. Quantification 
of opsin immunofluorescence(green) from ONL (outer nuclear layer, normalized as ratio of 
ONL:apical region encompassing IS and OS), and quantification of outer nuclear layer 
(ONL) thickness, expressed as averaged number of nuclei/column (indicated by Hoescht 
33342 staining) from 10μm cryosections from indicated genotypes at P21. (b) From part (a), 
Ahi1 null allele modifies the Nphp1−/− phenotype, with Nphp1−/−Ahi1+/− showing increased 
opsin accumulation and decreased thickness of the ONL versus Nphp1−/− and Ahi1+/− 
controls. Asterisk denotes significant difference from both Ahi1+/− and Nphp1−/−, n=6-7, 
P(ONL thickness)=0.00315 and 0.000106, respectively; and P(fluorescence)=0.0454 and 
0.0141, respectively, scale=20μm, error bars represent s.e.m.
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